🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to the team including Nizar MD Anderson Cancer Center Brian Rini, MD on first #siRNA #RCC phase 1 bit.ly/AROHIF2trial with ArrowheadPharma #HIF2 siRNA building upon bit.ly/siHIF2RCCpre (PMID36190432) opening new field.

Fantastic meeting of IMG Oncologists (37% of practicing oncologists in USA) steered by Toni Choueiri, MD Ziad Bakouny, MD, MSc Nazli Dizman 👉Challenges faced by IMGs, Insights from the 2023 meeting, how to join the group👇ASCO #ASCO24 #IMGCoP meeting overview 👇OncoAlert #ASCODailyNews

Excellent update session on management of #KidneyCancer #UROonco24. Thanks Antonio Alcaraz Riccardo Campi Selcuk Erdem Laura Marandino for the great input

We just closed the second edition of #IUCS24 great talks form Neeraj Agarwal, MD, FASCO Sumanta K. Pal, MD, FASCO Alison Tree 💙 Patrizia Giannatempo Yüksel Ürün Laura Marandino but also time to meet friends! Fabrizio Di Costanzo Emanuele Crupi Daniele Raggi Big thank you to Giuseppe Banna for another amazing meeting

We're delighted to lead a new project with @RoyalMarsdenNHS to study responses to cancer immunotherapy. The platform has received £20m+ in public and industry investment and will involve thousands of people from across the UK receiving immunotherapy. 🔗 crick.ac.uk/news-and-repor…

Delighted to announce the launch of our MANIFEST IO research platform MANIFEST IO. 🔬 We are a UK-wide consortium of academic institutions, NHS trusts & industry partners - with a shared vision to understand how patients with cancer can best benefit from immunotherapy. 🧵1/5

Engaging rapid-fire debate on kidney cancer management at #EMUC2024! Experts tackled challenges in surgery, systemic therapies, and the role of SBRT. Great insights into the future of personalized care. #KidneyCancer #UroOncology EAU-YAU Renal Cancer Working Group European Association of Urology (EAU)

I am incredibly honored and thrilled to take on this role and to work with the amazing editorial team of European Urology Oncology !

Fantastic talk by Daniele Raggi on ADCs in advanced urothelial Ca #BLADDR24 OncoAlert Mirrors of Medicine Huge progress, still many questions! Tom Powles Uromigos Matt Galsky Prof Ananya💙 @achoud72.bsky.social Maria Jiang Maria De Santis Saeed Dabestani Bernadett Szabados Shilpa Gupta Marinos Tsiatas Dra. María Natalia Gandur Quiroga

🌟 Variability of #Nectin-4 Positivity in #Genitourinary Malignancies: A Systematic Review 🔍 Want to find out more? You’re just a click away ⬇️ doi.org/10.1200/PO-24-… JCO Precision Oncology Ospedale San Raffaele Università Vita-Salute San Raffaele Daniele Raggi Andrea Necchi Philippe spiess Petros Grivas Ashish M. Kamat, MD, MBBS

📢 Join the Florence Multidisciplinary Expert Meeting on Renal Cell Carcinoma! 🗓 Dates: January 17-18, 2025 📍 Venue: Grand Hotel Mediterraneo, Florence Can’t attend in person? Follow the event online for free: ✅ Day 1: attendee.gotowebinar.com/register/87062… ✅ Day 2: attendee.gotowebinar.com/register/76662…

🚨 New study! 🚨Excited to share our research on #translocationRCC #tRCC published in Nature Metabolism, in collaboration with @lironbarpeled. We reveal how the TFE3 fusion drives a key oxidative phosphorylation (OXPHOS) metabolic program in this kidney cancer. 1/ Dana-Farber News

Eye-opening talk by Turajlic Lab @ The Crick on the future of biomarkers in #RCC, especially genomic, highlighting important challenges ASCO #GU25 The Crick OncLive.com Yüksel Ürün Emre Yekedüz

1/5 Sharing our Clinical Cancer Research work establishing serum CA-125 as a biomarker for #RenalMedullaryCarcinoma. This is now the first cancer-associated blood biomarker to become standard of care and used globally for a #kidneycancer : aacrjournals.org/clincancerres/… The V Foundation for Cancer Research Chris Johnson Foundation Inc.

Delighted to present our Turajlic Lab @ The Crick work on utilising AI-assisted high dimensional PBMC profiling to predict IO response and toxicity as a late breaking poster and talk at #AACRIO2025 today. Great collaboration with our partners at #IMUBiosciences as part of MANIFEST IO

Join Kidney Cancer Europe 2025: pre-conference surgical workshop Cutting-Edge on kidney focused on local therapies for advanced RCC YAU RCC will be there contributing to the conversation 🗓️ May 1, 2025 – Amsterdam 📍 Register at kidneycancer.org

Superstar panel of mentors AND mentees at the young investigators panel this morning! #IKCSEU25

🧬 Thanks to Margaret Ottaviano for the invitation to “Second Mediterranean Conference: Embracing Cancer Immunotherapy” 💉Stay hungry, don't stop learning, be inspired by the energy of research, don't stop dreaming that we can do even more! Congrats to all! OncoDaily IO OncoAlert

Excited to share our new review on the Management of Testicular Cancer just out in JCO Oncology Practice ! A practical overview on diagnosis, treatment, and survivorship. Robert Huddart💙 Alison Reid Walter Cazzaniga Deep Chakrabarti OncoAlert Check it out here: ascopubs.org/doi/10.1200/OP…

📢 #ASCO25 | NEOAVAX Ph II | High‐risk localized RCC: Neoadjuvant avelumab + axitinib × 12 wks pre‐nephrectomy in 40 pts: 30% ORR (12/40 PR), 20% median tumor downsizing; among responders, 10/12 were disease‐free at 23.5 mo median FU; no primary tumor progression.